Versartis to price initial public offering of 6 million common shares

Company to sell shares at $19.00 to $21.00; deal includes greenshoe

By Marisa Wong

Madison, Wis., March 19 - Versartis, Inc. plans to offer 6 million shares of common stock at $19.00 to $21.00 per share in its previously announced initial public offering, according to an FWP filing with the Securities and Exchange Commission.

The offering will have a greenshoe for 900,000 additional shares.

As previously noted, Morgan Stanley and Citigroup are the joint bookrunning managers. Cowen and Co. is the lead manager, and Canaccord Genuity is the co-manager.

Proceeds will be used for the phase 3 clinical trial of VRS-317, capital, capital expenditures and other general corporate purposes.

The endocrine-focused biopharmaceutical company is based in Redwood City, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.